Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$4.82 - $6.93 $8,521 - $12,252
-1,768 Reduced 4.28%
39,518 $205,000
Q4 2023

Feb 06, 2024

SELL
$5.63 - $8.27 $7,358 - $10,808
-1,307 Reduced 3.07%
41,286 $279,000
Q3 2023

Oct 26, 2023

SELL
$6.71 - $11.83 $73 - $130
-11 Reduced 0.03%
42,593 $285,000
Q2 2023

Aug 03, 2023

SELL
$11.12 - $22.2 $516,179 - $1.03 Million
-46,419 Reduced 52.14%
42,604 $488,000
Q1 2023

Apr 27, 2023

BUY
$18.7 - $23.07 $3,328 - $4,106
178 Added 0.2%
89,023 $1.79 Million
Q4 2022

Feb 01, 2023

SELL
$18.12 - $27.32 $11,306 - $17,047
-624 Reduced 0.7%
88,845 $2.01 Million
Q3 2022

Nov 01, 2022

BUY
$16.98 - $25.54 $322,704 - $485,387
19,005 Added 26.97%
89,469 $1.68 Million
Q2 2022

Jul 25, 2022

SELL
$13.15 - $20.45 $725,327 - $1.13 Million
-55,158 Reduced 43.91%
70,464 $1.31 Million
Q1 2022

Apr 21, 2022

SELL
$14.54 - $21.5 $441,187 - $652,374
-30,343 Reduced 19.46%
125,622 $2.27 Million
Q4 2021

Jan 18, 2022

BUY
$20.24 - $36.01 $21,474 - $38,206
1,061 Added 0.68%
155,965 $3.24 Million
Q3 2021

Oct 19, 2021

BUY
$26.01 - $38.22 $151,144 - $222,096
5,811 Added 3.9%
154,904 $4.96 Million
Q2 2021

Jul 30, 2021

BUY
$29.97 - $37.17 $1,198 - $1,486
40 Added 0.03%
149,093 $4.59 Million
Q1 2021

Apr 19, 2021

BUY
$29.24 - $42.03 $760,620 - $1.09 Million
26,013 Added 21.14%
149,053 $5.02 Million
Q4 2020

Jan 27, 2021

BUY
$35.35 - $50.67 $494 - $709
14 Added 0.01%
123,040 $4.45 Million
Q3 2020

Oct 07, 2020

SELL
$35.98 - $47.66 $4,821 - $6,386
-134 Reduced 0.11%
123,026 $4.53 Million
Q2 2020

Jul 24, 2020

BUY
$45.06 - $67.74 $827,752 - $1.24 Million
18,370 Added 17.53%
123,160 $5.55 Million
Q1 2020

Apr 30, 2020

SELL
$40.01 - $73.97 $16,324 - $30,179
-408 Reduced 0.39%
104,790 $4.97 Million
Q4 2019

Jan 07, 2020

SELL
$37.13 - $74.62 $302,980 - $608,899
-8,160 Reduced 7.2%
105,198 $7.54 Million
Q3 2019

Oct 04, 2019

BUY
$39.36 - $76.8 $295,751 - $577,075
7,514 Added 7.1%
113,358 $4.46 Million
Q2 2019

Jul 17, 2019

BUY
$52.76 - $82.19 $794,460 - $1.24 Million
15,058 Added 16.59%
105,844 $8.27 Million
Q1 2019

Apr 22, 2019

BUY
$27.39 - $68.41 $422,134 - $1.05 Million
15,412 Added 20.45%
90,786 $5.42 Million
Q4 2018

Feb 07, 2019

SELL
$22.8 - $33.93 $68,103 - $101,348
-2,987 Reduced 3.81%
75,374 $2.17 Million
Q3 2018

Nov 15, 2018

BUY
$29.75 - $43.08 $2.33 Million - $3.38 Million
78,361 New
78,361 $2.85 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Henry James International Management Inc. Portfolio

Follow Henry James International Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Henry James International Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Henry James International Management Inc. with notifications on news.